Important Safety Alerts

Important Safety Alerts

Medical Device Safety Alert: Abbott MULTIGENT Lithium and Alinity c Lithium Reagent Kit

16 Jul 2019

Medical device manufacturer, Abbott, has issued medical device safety alerts concerning its MULTIGENT Lithium assay and Alinity c Lithium Reagent Kit. The affected devices are identified as follow:

Abbott has received Field Safety Notices (FSNs) from Sentinel Diagnostic (the manufacturer of the affected products) to inform of the affected products have been updated with an additional SmartWash parameter to prevent the potential for carryover from the ARCHITECT Lactate Dehydrogenase (LDH) reagent (LN 2PS6) and the Alinity c Lactate Dehydrogenase (LDH) Reagent Kit (LN 07P74).

Carryover may be observed between the affected products and the LDH reagents (i.e. LN 2PS6 or LN 07P74) on improperly maintained systems due to the presence of lithium lactate in the LDH reagents.

According to the manufacturer, there is a potential to generate falsely elevated lithium patient results. To minimize the potential for carryover, an additional SmartWash has been implemented for the MULTIGENT or Alinity c Lithium assays.

Affected customers are advised to take the following actions:

According to the local supplier, the affected products are distributed in Hong Kong.

If you are in possession of the affected products, please contact your supplier for necessary actions.

Posted on 16 July 2019

Back